engleski

Platelet transfusion therapy

Since the 1960s, platelet transfusion therapy has played a vital role in the management of hematologic and oncologic patients with quite frequent disorder: thrombocytopenia. More than 2.9 million platelet components are transfused each year in Europe and 57, 000 in Croatia. Indeed, platelet transfusion has long been the subject of many debates and controversies, including the advantage of giving prophylactic compared to therapeutic transfusion, the trigger and/or threshold for platelet transfusion, the platelet collection method, and the optimal platelet dose to be transfused. Taking into account a short shelf life of PLTs compared to other blood components (5 to 7 days) and a growing demand for their use, each transfusion center must decide on its own priorities for providing a sufficient quantity of safe and effective PLT units.

Platelets; prophylactic; therapeutic transfusion; transfusion trigger

nije evidentirano